Literature DB >> 35464302

Comparison of different lymph node staging systems for predicting prognosis in patients with colon cancer who have undergone surgical resection.

Anna Madej-Mierzwa1, Mariusz Szajewski1,2, Wiesław Janusz Kruszewski1,2.   

Abstract

At present, the most widely used lymph node (LN) staging system in colon cancer is number of metastatic LNs in pathological assessment (pN) from the 8th edition of the TNM American Joint Committee on Cancer/Union for International Cancer Control staging system, which considers the number of metastatic LNs, omitting the total number of dissected LNs. The aim of the present study was to compare the prognostic performance of pN with alternative LN staging systems, including LN ratio (LNR) and log odds of positive LNs (LODDS). The clinical and histopathological data of 298 patients with colon cancer who underwent elective surgical resection in a single surgical centre were analysed. LNR and LODDS cut-off values according to two previous studies were selected to separate patients into different subgroups. Univariate and multivariate analyses were performed to distinguish prognostic factors. The three-step multivariate analysis showed that LNR was a superior prognostic indicator compared with pN and LODDS. Additionally, the Akaike Information Criterion, a measure of the relative quality of statistical models, confirmed that LNR displayed the best prognostic performance. Similarly, in a subpopulation of patients with number of dissected LNs (NDLN) ≥12, LNR was the most accurate LN staging system in relation to prognosis. In a subpopulation with NDLN <12, there was no significant difference in LN classification prognosis of 5-year overall survival; however, LNR and LODDS were more independent of NDLN than pN. Among the three LN classifications, LNR is the most accurate LN staging system for predicting prognosis for patients with colon cancer who have undergone surgical resection, particularly those with metastatic LNs subjected to adequate lymphadenectomy.
Copyright © 2022, Spandidos Publications.

Entities:  

Keywords:  LNR; LODDS; colon cancer; prognostic factor; survival analysis

Year:  2022        PMID: 35464302      PMCID: PMC9021845          DOI: 10.3892/ol.2022.13296

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system.

Authors:  Roberto Persiani; Ferdinando C M Cananzi; Alberto Biondi; Giuseppe Paliani; Andrea Tufo; Francesco Ferrara; Vincenzo Vigorita; Domenico D'Ugo
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

Review 2.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Authors:  George J Chang; Miguel A Rodriguez-Bigas; John M Skibber; Virginia A Moyer
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

3.  Impact of lymph node ratio on survival of colorectal cancer patients.

Authors:  Stefano Rausei; Domenico Iovino; Silvia Tenconi; Alberto Mangano; Davide Inversini; Luigi Boni; Francesca Rovera; Gianlorenzo Dionigi; Renzo Dionigi
Journal:  Int J Surg       Date:  2013       Impact factor: 6.071

4.  Log odds of positive lymph nodes is superior to the number- and ratio-based lymph node classification systems for colorectal cancer patients undergoing curative (R0) resection.

Authors:  Hong Yan Fang; Hui Yang; Zhong Shi He; Hong Zhao; Zhen Ming Fu; Fu Xiang Zhou; Yun Feng Zhou
Journal:  Mol Clin Oncol       Date:  2017-03-22

5.  Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Authors:  Adam C Berger; Elin R Sigurdson; Thomas LeVoyer; Alexandra Hanlon; Robert J Mayer; John S Macdonald; Paul J Catalano; Daniel G Haller
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

6.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

7.  The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

8.  Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes?

Authors:  Yong-Xi Song; Peng Gao; Zhen-Ning Wang; Lin-Lin Tong; Ying-Ying Xu; Zhe Sun; Cheng-Zhong Xing; Hui-Mian Xu
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

9.  The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer.

Authors:  Chi-Hao Zhang; Yan-Yan Li; Qing-Wei Zhang; Alberto Biondi; Valeria Fico; Roberto Persiani; Xiao-Chun Ni; Meng Luo
Journal:  Front Oncol       Date:  2018-12-18       Impact factor: 6.244

10.  Prognosis of colorectal cancer patients is associated with the novel log odds of positive lymph nodes scheme: derivation and external validation.

Authors:  Qing-Wei Zhang; Chi-Hao Zhang; Yuan-Bo Pan; Alberto Biondi; Valeria Fico; Roberto Persiani; Shan Wu; Yun-Jie Gao; Hui-Min Chen; Ou-Min Shi; Zhi-Zheng Ge; Xiao-Bo Li
Journal:  J Cancer       Date:  2020-01-16       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.